机译:转移性肾细胞癌并发弥漫性肺泡出血:舒尼替尼的罕见不良反应
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Department of Molecular and Cellular Pathology, Kanazawa University, Kanazawa, Japan;
Cancer Center, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan;
Sunitinib; Alveolar hemorrhage; Adverse effect; Papillary renal cell carcinoma; Vascular endothelial growth factor;
机译:转移性肾细胞癌并发弥漫性肺泡出血:舒尼替尼的罕见不良反应。
机译:Re:第一线瑞替尼与Pazopanib在转移性肾细胞癌中:国际转移性肾细胞癌数据库联盟的结果
机译:一线舒尼替尼与帕唑帕尼治疗转移性肾细胞癌:国际转移性肾细胞癌数据库联盟的结果
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
机译:舒尼替尼治疗转移性肾细胞癌患者:根据国际转移性肾细胞癌数据库联合会风险组的临床结果
机译:metastatic renal cell carcinoma complicated with diffuse alveolar hemorrhage: a rare adverse effect of sunitinib